United States

Back to map

Showing 1-10 of 56 grants

Title Institution Researcher Program Duration Total Award Amount
Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D Yale University Alfonso Galderisi Cures 01-February-2023 to 30-September-2026 $747,380.88
Assess the antigenic profile in human T1D: from β-cell crinophagy to peripheral blood Washington University Xiaoxiao Wan Cures 01-April-2022 to 31-March-2027 $750,000.00
Discovering early diagnostic markers of cardiovascular disease risk with lipidomics in a 30-year longitudinal prospective type 1 diabetes cohort University of Wisconsin-Madison (Board of Regents University of Wisconsin System) Judith Simcox Improving Lives 01-November-2022 to 04-May-2026 $799,988.63
Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes University of Washington Ian De Boer Improving Lives 01-September-2023 to 31-March-2028 $2,107,411.00
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2026 $890,372.53
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? University of Texas Health Science Center at San Antonio Muhammad Abdul-Ghani Improving Lives 01-June-2019 to 31-December-2026 $1,573,835.31
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D University of Florida Graciela Lorca Cures 01-September-2019 to 31-August-2026 $355,941.78
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression University of Florida Sarah Kim Cures 01-June-2022 to 31-May-2026 $744,090.11
Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial University of California, San Diego Charles Ginsberg Improving Lives 01-November-2022 to 31-October-2026 $1,356,726.45
The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes University of California, San Diego Jeremy Pettus Improving Lives 01-June-2021 to 30-November-2026 $1,233,752.52